TREXIT
Brief description of study
To compare infection adverse events of TP-Bx vs. TR-Bx performed under local anesthesia. Targeted population are men aged at least 18 years with: history of Grade Group 1 or 2 prostate cancer, first diagnosed prior to date of planned biopsy. The study is designed as a prospective, randomized trial with 1:1 ratio to either the transperineal or transrectal biopsy group. Participants will be assessed for adverse events, pain and discomfort immediately and 7 days post-biopsy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
